This is the part I like:
ResappDx-EU has the potential to have far reaching benefits in the healthcare system and we will now rapidly move ahead with our European commercialisation strategy
Ann: ResApp Receives CE Mark for ResAppDx-EU, page-36
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #